ENVALITH
日本化薬株式会社 logo

NIPPON KAYAKU CO.,LTD.

4272Prime MarketChemicals

日本化薬株式会社 logo
NIPPON KAYAKU CO.,LTD.4272
Reference Indicators

Market Cap

3,166¥100M

P/E (Forecast)

P/B

1.1x

Dividend Yield (Forecast)

3.34%

ROE

9.0%

EV/EBITDA

8.3x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
184,805198,380201,791222,584241,851
Cost of Sales
120,837131,627140,490151,102168,971
Gross Profit
63,96766,75261,30171,48272,880
SG&A Expenses
42,91645,24753,96451,08050,426
Operating Income
21,05021,5057,33720,40122,454
Non-operating Income
2,4952,5166,0152,9444,149
Non-operating Expenses
3919967901,0801,125
Ordinary Income
23,15423,02512,56222,26625,478
Extraordinary Income
1,7851,3772,1713,8589,661
Extraordinary Losses
1,2383,4317,5274,1171,546
Pre-tax Income
23,70020,9727,20522,00733,592
Income Taxes
6,4555,9293,0264,4288,880
Net Income
17,18114,9844,11317,50824,641
EBITDA
35,14935,74521,73934,47838,213
Gross Margin
34.6%33.6%30.4%32.1%30.1%
Operating Margin
11.4%10.8%3.6%9.2%9.3%
ROA
5.4%4.6%1.1%4.7%6.2%
ROE
7.3%6.0%1.6%6.5%9.0%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
モビリティ&イメージング事業領域94,71410,65411.2%
ファインケミカルズ事業領域74,14211,92916.1%
ライフサイエンス事業領域72,9949,68013.3%
その他000.0%